
Dermatology Clinical Trials
Westgate Skin & Cancer is actively recruiting for paid dermatology research studies and paid dermatology clinical trials. All paid studies and trials are federally regulated, completely optional, and help society by advancing the state of medicine.
We encourage all patients who may be interested in compensation, addressing their condition, and learning more about their condition to consider participating. Westgate Skin & Cancer has partnered with Tekton Research, a leading research institute in South Austin, to provide paid research studies in the greater Austin metro area. Dr. Blakely Richardson, a board certified dermatologist, leads all dermatology research studies as the Principal Investigator (PI).
Open Trials
About Tekton Research
Tekton Research was established in 2006 and has successfully completed hundreds of clinical trials and research studies in the Austin area. In addition to dermatology research studies, Tekton Research conducts healthy volunteer research studies and clinical trials for many medical conditions. Tekton Research is conveniently located 2 blocks from Westgate Skin & Cancer in the West Tower Village. For more information, visit www.tektonresearch.com.
Research Study Q&A
Clinical trials are federally regulated, subject to strict rules, and are physician lead. Federal oversight ensures that the highest quality of care is provided during the study. We've assembled a Q&A section for common questions.
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people. Overall, clinical trials produce the best data available for health care decision-making.
Dr. Blakely Richardson, and the professionals at Tekton Research, manage dermatological clinical trials in the Austin area for national and international pharmaceutical companies.
The purpose of a clinical trial is research. Subsequently, strict scientific standards are followed at all times throughout a study. These standards help to protect patients and to produce reliable study results. Specific to the specialty of dermatology, clinical trials help the advancement of knowledge for the entire specialty. This advancement provides future dermatologist with the best clinical data available for dermatological decision making.
This can happen and can be caused by many different reasons. Clinical trials, the provided care, and the provided medications are not a guarantee. Clinical trials are conducted for the purposes of advancing medical knowledge. Ultimately, all results from a clinical trial are important and valuable to improve patient care, even if the results might be undesirable.
The short answer is commonly yes. Most dermatology clinical trials are compensated in some way, however, the type of compensation and the form of compensation can vary. All clinical trials are inherently unique due to the location, timeframe, medication, treatment, device, or illness being studied.
Compensation can range from a monetary payment, receipt of a study medication, receipt of study care, receipt of a device, early access to the previously mentioned, and or all of the above. Every study is different and should be reviewed by the participant for a full understanding of potential benefits.
Yes, all dermatology clinical trials lead by Dr. Blakely Richardson, and the professionals at Tekton Research, are federally regulated and overseen by United States Food and Drug Administration (FDA). Additionally, dermatology clinical trials may have involvement from the National Institute of Health (NIH).